Inventor · disambiguated record
Justin Chapman
Also filed as: CHAPMAN JUSTIN · CHAPMAN JUSTIN GUY
8 granted patents·14 pending applications·7 citations·filing 2004–2024
78Inventor score
Files withSOVA PHARMACEUTICALS INC6CULLINAN MICA CORP4SITARI PHARMA INC3MISFOLDING DIAGNOSTICS INC2PFIZER2
Top patents by PatentIndex Score
22 records- 0192US11548892B1Transglutaminase 2 (TG2) inhibitorsSITARI PHARMA INC·Filed 2022·Granted Jan 10, 2023·4 cites·6 claims
- 0281US12065493B2Anti-MICA/B antibodies that block MICA/B shedding and methods of useCULLINAN MICA CORP·Filed 2021·Granted Aug 20, 2024·1 cites·16 claims
- 0378US2025011324A1Transglutaminase 2 (tg2) inhibitorsSITARI PHARMA INC·Filed 2024·Application pending·0 cites
- 0469US10227314B2Cystathionine-gamma-lyase (CSE) inhibitorsSOVA PHARMACEUTICALS INC·Filed 2017·Granted Mar 12, 2019·1 cites·9 claims
- 0569US2025034262A1Anti-mica/b antibodies that block mica/b shedding and methods of useCULLINAN MICA CORP·Filed 2024·Application pending·0 cites
- 0666US2024067731A1Mica/b antibodies and methods of useCULLINAN MICA CORP·Filed 2023·Application pending·0 cites
- 0764US12152026B2Transglutaminase 2 (TG2) inhibitorsSITARI PHARMA INC·Filed 2019·Granted Nov 26, 2024·0 cites·27 claims
- 0864US9790269B2Transthyretin antibodies and uses thereofMISFOLDING DIAGNOSTICS INC·Filed 2014·Granted Oct 17, 2017·1 cites·19 claims
- 0954US2021047417A1Mica/b antibodies and methods of useCULLINAN MICA CORP·Filed 2020·Application pending·0 cites
- 1053US2004235019A1Diagnostics and therapeutics for the gene expression signature of PPAR-gamma receptor ligandAGOURON PHARMA·Filed 2004·Application pending·0 cites
- 1151US9771339B2Cystathionine-γ-lyase (CSE) inhibitorsSOVA PHARMACEUTICALS INC·Filed 2013·Granted Sep 26, 2017·0 cites·15 claims
- 1251US9725426B2Cystathionine-γ-lyase (CSE) inhibitorsSOVA PHARMACEUTICALS INC·Filed 2013·Granted Aug 8, 2017·0 cites·19 claims
- 1348US2021122819A1Anti-lilrb antibodies and uses thereofADANATE INC·Filed 2019·Application pending·0 cites
- 1443US2017327478A1Cystathionine-gamma-lyase (cse) inhibitorsSOVA PHARMACEUTICALS INC·Filed 2017·Application pending·0 cites
- 1541US2019284274A1Erfe specific antibodies compositions and methods of useSILARUS THERAPEUTICS INC·Filed 2017·Application pending·0 cites
- 1641US2020040054A1Erfe fusion polypeptides compositions and methods of useSILARUS THERAPEUTICS INC·Filed 2017·Application pending·0 cites
- 1741US2018022797A1Transthyretin antibodies and uses thereofMISFOLDING DIAGNOSTICS INC·Filed 2017·Application pending·0 cites
- 1841US2011008328A1Method for controlling glucose uptake and insulin sensitivityPFIZER·Filed 2008·Application pending·0 cites
- 1938US10654833B2ASK1 isoindolin-1-one inhibitors and methods of use thereofHEPATIKOS THERAPEUTICS LLC·Filed 2019·Granted May 19, 2020·0 cites·18 claims
- 2038US2015272934A1Use of cse inhibitors for the treatment of cutaneous injuries or conditions and sleep-related breathing disordersSOVA PHARMACEUTICALS INC·Filed 2013·Application pending·0 cites
- 2132US2011165170A1Osteopontin antibodiesPFIZER·Filed 2010·Application pending·0 cites
- 2227US2015202186A1CYSTATHIONINE-(gamma)-LYASE (CSE) INHIBITORS FOR TREATING PAINSOVA PHARMACEUTICALS INC·Filed 2015·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Justin Chapman files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →